Last reviewed · How we verify
Capimorelin (CAPROMORELIN)
At a glance
| Generic name | CAPROMORELIN |
|---|---|
| Target | Growth hormone secretagogue receptor type 1, Growth hormone secretagogue receptor type 1 |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Approved indications
Common side effects
- Diarrhea
- Vomiting
- Elevated blood urea nitrogen
- Polydipsia
- Hypersalivation
- Elevated phosphorus
- Abdominal discomfort
- Flatulence
- Nausea
- Lethargy/depression
- Elevated creatinine
- Hyperactivity
Serious adverse events
- Loss of consciousness
- Ataxia
- Disorientation
- Dyspnea
- Bradycardia
- Hypotension
- Recumbency
- Weakness
- Hyperglycemia
- Sedation